Skip to main content
Log in

Kardio- und neurotoxische Nebenwirkungen nach akzidenteller intravasaler Bupivacainapplikation

Therapie mit Lidocain, Propofol und Lipidemulsion

Cardiotoxic and neurotoxic effects after accidental intravascular bupivacaine administration

Therapy with lidocaine propofol and lipid emulsion

  • Kasuistiken
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Eine akzidentelle intravasale Bupivacainapplikation kann schwere neuro- und kardiotoxische Nebenwirkungen verursachen. Es wird über einen Fall einer vermuteten Bupivacainintoxikation nach intravasaler Applikation über einen Periduralkatheter berichtet, deren Behandlung mithilfe Lidocain, Propofol und 20%iger Lipidemulsion zu schnellem Sistieren der kardio- und neurotoxischen Effekte führte. Mögliche Wirkmechanismen der verwendeten Medikamente werden diskutiert.

Abstract

Accidental intravascular administration of bupivacaine can cause severe neurotoxic and cardiotoxic effects. We report a case of suspected bupivacaine intoxication due to intravascular injection via an epidural catheter and treatment with lidocain, propofol, and a 20% lipid emulsion resulting in fast resolution of cardiotoxic and neurotoxic effects. Possible mechanisms of action of the medications used are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Auroy Y, Narchi P, Messiah A et al. (1997) Serious complications related to regional anesthesia: results of a prospective survey in France. Anesthesiology 87: 479–486

    Article  PubMed  Google Scholar 

  2. Clarkson CW, Hondeghem LM (1985) Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 62: 396–405

    Article  PubMed  Google Scholar 

  3. Heavner J, Arthur J, Zou J et al. (1993) Comparison of propofol with thiopentone for treatment of bupivacaine-induced seizures in rats. Br J Anaesth 71: 715–719

    Article  PubMed  Google Scholar 

  4. Knudsen K, Beckmann Suurküla M, Blomberg S et al. (1997) Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 78: 507–514

    PubMed  Google Scholar 

  5. Litz RJ, Popp M, Stehr SN, Koch T (2006) Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anaesthesia 61: 800–801

    Article  PubMed  Google Scholar 

  6. Moller RA, Govino BG (1988) Cardiac electrophysiologic effects of lidocaine and bupivacaine. Anesth Analg 67: 107–114

    Article  PubMed  Google Scholar 

  7. Morishima H, Pedersen H, Finster M et al. (1985) Bupivacaine toxicity in pregnant and nonpregnant ewes. Anesthesiology 63: 134–139

    Article  PubMed  Google Scholar 

  8. Mulroy MF (2002) Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med 27: 556–561

    Article  PubMed  Google Scholar 

  9. Ohmura S, Ohta T, Yamamoto K, Kobayashi T (1999) A comparison of the effects of propofol and sevoflurane on the systemic toxicity of intravenous bupivacaine in rats. Anesth Analg 88: 155–159

    Article  PubMed  Google Scholar 

  10. Rosenblatt MA, Abel M, Fischer GW et al. (2006) Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine related cardiac arrest. Anesthesiology 105: 217–218

    Article  PubMed  Google Scholar 

  11. Veering BT, Burm AG, Vletter AA et al. (1991) The effect of age on systemic absorption and systemic disposition of bupivacaine after subarachnoid administration. Anesthesiology 74: 250–257

    Article  PubMed  Google Scholar 

  12. Weinberg GL, VadeBoncouer T, Ramaraju GA et al. (1998) Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 88: 1071–1075

    Article  PubMed  Google Scholar 

  13. Weinberg GL, Ripper R, Feinstein DL, Hoffman W (2003) Lipid emulsion infusion rescues dogs from bupivacain-induced cardiac toxicity. Reg Anesth Pain Med 28: 198–202

    Article  PubMed  Google Scholar 

  14. Weinberg GL, Ripper R, Murphy P et al. (2006) Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med 31: 296–303

    Article  PubMed  Google Scholar 

  15. Weinberg GL (2006) Lipid infusion resuscitation for local anesthetic toxicity. Proof of clinical efficacy. Anesthesiology 105: 7–8

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Zimmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmer, C., Piepenbrink, K., Riest, G. et al. Kardio- und neurotoxische Nebenwirkungen nach akzidenteller intravasaler Bupivacainapplikation. Anaesthesist 56, 449–453 (2007). https://doi.org/10.1007/s00101-007-1147-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-007-1147-3

Schlüsselwörter

Keywords

Navigation